Search filters

List of works by Patrick G Gavin

A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes

scientific article

Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial.

scientific article

Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial.

scientific article published on 06 June 2016

Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

scientific article published on 22 January 2020

Correction to: Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota.

scientific article published on 20 March 2018

Immune Signature to Predict Trastuzumab Benefit: Potential and Pitfalls.

scientific article published on 17 August 2015

Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31

scientific article published on 17 October 2019

Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes

scientific article published on 12 August 2018

Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial

scientific article

Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations

scientific article published in PLoS ONE

Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value

scientific article

NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

scientific article published on 03 December 2019

Neratinib plus Cetuximab in Quadruple WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study

scientific article published on 17 November 2020

Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.

scientific article

Prognostic Role of Immunoglobulin G Fragment C Receptor Polymorphisms in Solid Tumors-Reply

scientific article published on 28 September 2017

Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer

scientific article published on 01 August 2019

The gut microbiota in type 1 diabetes: friend or foe?

scientific article published on 01 August 2019

Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology)

scientific article published on 14 December 2017

Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota

scientific article published on 17 February 2018

Paulina is supported by:

About Paulina

Help